Acumen Pharmaceuticals, Inc. (ABOS) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Newton, VA, 미국. 현재 CEO는 James Doherty.
ABOS 을(를) 보유 IPO 날짜 2021-07-01, 61 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $162.34M.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
